TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
38 hedge funds and large institutions have $99.3M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
46% more funds holding
Funds holding: 26 → 38 (+12)
Holders
38
Holding in Top 10
2
Calls
$106K
Puts
$14K
Top Buyers
| 1 | +$6.49M | |
| 2 | +$5.91M | |
| 3 | +$3.75M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.47M |
| 5 |
Two Sigma Advisers
New York
|
+$2.97M |
Top Sellers
| 1 | -$523K | |
| 2 | -$413K | |
| 3 | -$324K | |
| 4 |
VF
Virtu Financial
New York
|
-$316K |
| 5 |
LC
Lindbrook Capital
Calabasas,
California
|
-$52K |